These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11232608)

  • 21. Inappropriate detection of supraventricular arrhythmias by implantable dual chamber defibrillators: a comparison of four different algorithms.
    Hintringer F; Schwarzacher S; Eibl G; Pachinger O
    Pacing Clin Electrophysiol; 2001 May; 24(5):835-41. PubMed ID: 11388103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing.
    Kühlkamp V; Dörnberger V; Mewis C; Suchalla R; Bosch RF; Seipel L
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):905-15. PubMed ID: 10413370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators.
    Love BA; Barrett KS; Alexander ME; Bevilacqua LM; Epstein MR; Triedman JK; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1097-101. PubMed ID: 11699514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?
    Sweeney MO; Ruetz LL; Belk P; Mullen TJ; Johnson JW; Sheldon T
    J Am Coll Cardiol; 2007 Aug; 50(7):614-22. PubMed ID: 17692746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?
    Stein KM; Euler DE; Mehra R; Seidl K; Slotwiner DJ; Mittal S; Markowitz SM; Lerman BB;
    J Am Coll Cardiol; 2002 Jul; 40(2):335-40. PubMed ID: 12106941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of inappropriate shocks in ICD recipients: a review of 10,000 tachycardia episodes.
    Anselme F; Mletzko R; Bowes R; Mabo P; Sadoul N; Schoels W; Seidl K; Schwab J; Iscolo N; Nitzsché R
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S128-33. PubMed ID: 17302688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator.
    Dorian P; Philippon F; Thibault B; Kimber S; Sterns L; Greene M; Newman D; Gelaznikas R; Barr A;
    Heart Rhythm; 2004 Nov; 1(5):540-7. PubMed ID: 15851216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
    Zareba W; Daubert JP; Beck CA; Huang DT; Alexis JD; Brown MW; Pyykkonen K; McNitt S; Oakes D; Feng C; Aktas MK; Ayala-Parades F; Baranchuk A; Dubuc M; Haigney M; Mazur A; McPherson CA; Mitchell LB; Natale A; Piccini JP; Raitt M; Rashtian MY; Schuger C; Winters S; Worley SJ; Ziv O; Moss AJ;
    J Am Coll Cardiol; 2018 Aug; 72(6):636-645. PubMed ID: 30071993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
    J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.
    Friedman PA; Bradley D; Koestler C; Slusser J; Hodge D; Bailey K; Kusumoto F; Munger TM; Militanu A; Glikson M
    Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of a new single-chamber ICD algorithm: discrimination of supraventricular and ventricular tachycardia based on vector timing and correlation.
    Corbisiero R; Lee MA; Nabert DR; Coman JA; Breiter DJ; Schwartz M; McKittrick E; Zhang Y
    Europace; 2006 Dec; 8(12):1057-61. PubMed ID: 17105781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pitfalls of the concept of incremental specificity used in comparisons of dual chamber VT/VF detection algorithms.
    Malik M
    Pacing Clin Electrophysiol; 2000 Jul; 23(7):1166-70. PubMed ID: 10914375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: state-of-the-art review.
    Swerdlow CD
    J Cardiovasc Electrophysiol; 2001 May; 12(5):606-12. PubMed ID: 11386525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia.
    Kouakam C; Kacet S; Hazard JR; Ferraci A; Mansour H; Defaye P; Davy JM; Lambiez M;
    Europace; 2004 Jan; 6(1):32-42. PubMed ID: 14697724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial.
    Gold MR; Ahmad S; Browne K; Berg KC; Thackeray L; Berger RD
    Heart Rhythm; 2012 Mar; 9(3):370-7. PubMed ID: 21978966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
    Ricci RP; Quesada A; Almendral J; Arribas F; Wolpert C; Adragao P; Zoni-Berisso M; Navarro X; DeSanto T; Grammatico A; Santini M;
    Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.